08:00 , Jan 23, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Asthma; allergy Oxoeicosanoid receptor 1 (OXER1; GPR170) In vitro studies identified OXER1 antagonists that could help treat asthma and allergic diseases. Compounds that incorporated an...